Quality of Life and Financial Impacts of Permanent Colostomy for Rectal Cancer

 

 Permissions and Reprints

Abstract

Introduction Returning to work is an important cancer recovery milestone. Permanent colostomy can be required for rectal cancer treatment and can significantly impact well-being. We aimed to evaluate the impact of permanent colostomy on health-related quality of life and return to work in patients with rectal cancer.

Methods This was a retrospective cohort study on 23 employed patients receiving curative surgery for rectal cancer requiring permanent colostomy. Demographic and health-related quality-of-life questionnaires (the Colostomy Impact Score (CIS), the EORTC Quality of Life Questionnaire (QLQ)-C30, and the EORTC QLQ-CR29) were posted to eligible patients.

Results On average, patients (10 female, 13 male, mean age 61.8 years) were 5.0 ± 3.5 years post-surgery. At the time of questioning, 73.9% had returned to work (21.7% changed their type of work), while 17.4% never returned to work. Of those that returned to work, 11.8% returned within 1 month of surgery, while 23.5% had not returned after 12 months. Comparison of CIS between patients that returned to the same work (14.6 ± 0.93), changed their work (13.0 ± 0.74), and did not return to work (14.3 ± 2.3) revealed no significant differences (p = 0.36). CIS did not correlate with days worked on return, or time to return to work (p > 0.05).

Conclusion Returning to work following rectal cancer treatment with permanent colostomy is challenging, with 17.4% never returning to work. Of those who returned to work, 23.5% required more than 12 months. This was not associated with CIS in our study.

Danish Cancer Society Centre for Research on Survivorship and Late Adverse Effects After Cancer in the Pelvic Organs.

Publication History

Received: 25 December 2023

Accepted: 07 February 2024

Article published online:
11 March 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

• References

• 1 Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet 2014; 383 (9927) 1490-1502
  CrossrefPubMedGoogle Scholar
• 2 Dagher H, Ahern S, Egwunye J. et al. The 2020 Data Binational Colorectal Cancer Audit Report. 2021
  PubMedGoogle Scholar
• 3 Codd RJ, Evans MD, Davies M. et al. Permanent stoma rates: a misleading marker of quality in rectal cancer surgery. Colorectal Dis 2014; 16 (04) 276-280
  CrossrefPubMedGoogle Scholar
• 4 Pachler J, Wille-Jørgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev 2012; 12 (12) CD004323
  PubMedGoogle Scholar
• 5 Kristensen HO, Thyø A, Jøssing Emmertsen K. et al. Translation and international validation of the Colostomy Impact score. Colorectal Dis 2021; 23 (07) 1866-1877
  CrossrefPubMedGoogle Scholar
• 6 Thyø A, Emmertsen KJ, Pinkney TD, Christensen P, Laurberg S. The colostomy impact score: development and validation of a patient reported outcome measure for rectal cancer patients with a permanent colostomy. A population-based study. Colorectal Dis 2017; 19 (01) O25-O33
  CrossrefPubMedGoogle Scholar
• 7 Aaronson NK, Ahmedzai S, Bergman B. et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85 (05) 365-376
  CrossrefPubMedGoogle Scholar
• 8 Gujral S, Conroy T, Fleissner C. et al; European Organisation for Research and Treatment of Cancer Quality of Life Group. Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. Eur J Cancer 2007; 43 (10) 1564-1573
  CrossrefPubMedGoogle Scholar
• 9 Scott N, Fayers P, Aaronson N. et al. EORTC QLQ-C30 Reference Values. Belgium: Quality of Life Department, EORTC, 2008
  PubMedGoogle Scholar
• 10 den Bakker CM, Anema JR, Huirne JAF, Twisk J, Bonjer HJ, Schaafsma FG. Predicting return to work among patients with colorectal cancer. Br J Surg 2020; 107 (01) 140-148
  CrossrefPubMedGoogle Scholar
• 11 Gordon LG, Beesley VL, Lynch BM. et al. The return to work experiences of middle-aged Australian workers diagnosed with colorectal cancer: a matched cohort study. BMC Public Health 2014; 14: 963
  CrossrefPubMedGoogle Scholar
• 12 den Bakker CM, Anema JR, Zaman AGNM. et al. Prognostic factors for return to work and work disability among colorectal cancer survivors; A systematic review. PLoS One 2018; 13 (08) e0200720
  CrossrefPubMedGoogle Scholar
• 13 Law CK, Brewer K, Brown C. et al; Australasian Gastro-Intestinal Trials Group (AGITG) ALaCaRT investigators. Return to work following laparoscopic-assisted resection or open resection for rectal cancer: Findings from AlaCaRT-Australasian Laparoscopic Cancer of the Rectum Trial. Cancer Med 2021; 10 (02) 552-562
  CrossrefPubMedGoogle Scholar
• 14 van den Brink M, van den Hout WB, Kievit J. et al. The impact of diagnosis and treatment of rectal cancer on paid and unpaid labor. Dis Colon Rectum 2005; 48 (10) 1875-1882
  CrossrefPubMedGoogle Scholar
• 15 Chen L, Glimelius I, Neovius M. et al. Work loss duration and predictors following rectal cancer treatment amongst patients with and without prediagnostic work loss. Cancer Epidemiol Biomarkers Prev 2016
  PubMedGoogle Scholar
• 16 Hornbrook MC, Grant M, Wendel C. et al. Rectal cancer survivors' participation in productive activities. Perm J 2018; 22: 17-022
  CrossrefPubMedGoogle Scholar
• 17 Rottenberg Y, de Boer AGEM. Risk for unemployment at 10 years following cancer diagnosis among very long-term survivors: a population based study. J Cancer Surviv 2020; 14 (02) 151-157
  CrossrefPubMedGoogle Scholar